SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Wire to Wire Daily Stock Picking -- Ignore unavailable to you. Want to Upgrade?


To: Lazarus who wrote (1214)7/8/1999 7:26:00 PM
From: Jeffrey L. Henken  Read Replies (1) | Respond to of 3514
 
REPR is in! Out of the bargain bin and into the race!

Talk about numb nuts.

biz.yahoo.com

REPR is engaged in the research, development, production and marketing of medical devices. REPR's main product is the Testicular Hypothermia Device (THD), which is used to improve semen quality in males. For the nine months ended 11/30/98, totalled revenues fell 27% to $1.4 million. Net loss applicable to Comm. totalled $277 thousand vs. an income of $80 thousand. Results suffered from the absence of $708 thousand in revenues from the sale of the Company's impotence treatment technology.

Oooooh that's so cold!

BISN - Popiye - Float 100 million - 0.023 x 0.025 - #reply-10430338
EBNK - Fred Langford - Float 3.4 Mil - 9 1/8 x 9 1/4 - #reply-10431870
INFO - Micropicker - Float 6.1 million - 5 15/16 x 6 - News just out!
REPR - Lazarus - Float 10 million - .04 x .05 - #reply-10432948

finance.yahoo.com

Thanks, Jeff